Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

NCT00300729 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

319

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Celecoxib
DRUG: Placebo

Sponsor

University Hospital, Linkoeping

Collaborators

[object Object]
[object Object]